Prolactin in Ovarian Follicular Fluid Stimulates Endothelial Cell Proliferation

Journal of Vascular Research

Volumn 47, Issue 1, 2009, Pages 45-53

  Castilla, Alejandra ^a   García, Celina ^a   Cruz Soto, Martha ^a   Martínez De La Escalera, Gonzalo ^a   Thebault, Stéphanie ^a   Clapp, Carmen ^a  

^a CENTRO DE FÍSICA APLICADA Y TECNOLOGÍA AVANZADA   (Mexico)

Author keywords

Angiogenesis; Endothelial cell proliferation; Follicular fluid; Ovarian follicle; Prolactin receptor; Vascular endothelium

Indexed keywords

JANUS KINASE 2; PROLACTIN; PROLACTIN RECEPTOR; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; NONHUMAN; OVARY FOLLICLE FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN;

ANIMALS; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; FOLLICULAR FLUID; JANUS KINASE 2; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROLACTIN; PROTEIN ISOFORMS; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS;

EID: 68349109556     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000231720     Document Type: Article

References (44)

1. Abulafia O, Sherer DM: Angiogenesis of the ovary. Am J Obstet Gynecol 2000; 182:240-246.
2. Gospodarowicz D, Cheng J, Lui GM, Baird A, Esch F, Bohlen P: Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 1985; 117:2383-2391.
3. Hayashi KG, Acosta TJ, Tetsuka M, Berisha B,Matsui M, Schams D, Ohtani M, Miyamoto A: Involvement of angiopoietin-tie system inbovine follicular development and at resia: messenger RNA expression in the cainterna and effect on steroid secretion. Biol Reprod 2003; 69:2078-2084.
4. Bagavandoss P, Sage EH, Vernon RB: Secreted protein, acidic and rich in cysteine (SPARC) and thrombospondin in the developing follicle and corpus luteum of the rat. J Histochem Cy tochem 1998; 46:1043-1049.
5. Fraser HM, Duncan WC: Vascular morphogenesis in the primate ovary. Angiogenesis 2005; 8:101-116.
6. Clapp C, Thebault S, Martinezdela Escalera G: Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland. J Mammary Gland Biol Neoplasia 2008; 13:55-67.
7. Laufer N, Botero-Ruiz W, DeCherney AH, Haseltine F, Polan ML, Behrman HR: Go-nadotropin and prolactin levels in follicular fluid of human ova successfully fertilized in vitro. J Clin Endocrinol Metab 1984; 58:430-434.
8. Clapp C, Aranda J, Gonzalez C, Jeziorski MC, Martinez de la Escalera G: Vasoinhib-ins: endogenous regulators of angiogenesis and vascular function. Trends Endocrinol Metab 2006; 17:301-307.
9. Ueda E, Ozerdem U, Chen YH, Yao M, Huang KT, Sun H, Martins-Green M, Barto-lini P, Walker AM: A molecular mimic demonstrates that phosphorylated human pro-lactin is a potent anti-angiogenic hormone. Endocr Relat Cancer 2006; 13:95-111.
10. Gaytan F, Morales C, Bellido C, Aguilar E, Sanchez-Criado JE: Role of prolactin in the regulation of macrophages and in the prolif-erative activity of vascular cells in newly formed and regressing rat corpora lutea. Biol Reprod 1997; 57:478-486.
11. Grosdemouge I, Bachelot A, Lucas A, Baran N, Kelly PA, Binart N: Effects of deletion of the prolactin receptor on ovarian gene expression. Reprod Biol Endocrinol 2003; 1:12.
12. Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V, Weiner RI, Martial JA: Opposing actions of intact and N-terminal fragments of the human prolactin/ growth hormone family members on angio-genesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 1999; 96:1246-1251.
13. Ko JY, Ahn YL, Cho BN: Angiogenesis and white blood cell proliferation induced in mice by injection of a prolactin-expressing plasmid into muscle. Mol Cells 2003; 15:262-270.
14. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luch-tefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007; 128:589-600.
15. Ricken AM, Traenkner A, Merkwitz C, Hummitzsch K, Grosche J, Spanel-Borowski K: The short prolactin receptor predominates in endothelial cells of micro-and mac-rovascular origin. J Vasc Res 2007; 44:19-30.
16. Malaguarnera L, Pilastro MR, Quan S, Ghattas MH, Yang L, Mezentsev AV, Kushida T, Abraham NG, Kappas A: Significance of heme oxygenase in prolactin-mediated cell proliferation and angiogenesis in human en-dothelial cells. Int J Mol Med 2002; 10:433-440.
17. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knock-out mice. Endocr Rev 1998; 19:225-268.
18. Merkle CJ, Schuler LA, Schaeffer RC Jr, Grib-bon JM, Montgomery DW: Structural and functional effects of high prolactin levels on injured endothelial cells: evidence for an endothelial prolactin receptor. Endocrine 2000; 13:37-46.
19. Cruz J, Avina-Zubieta A, Martinez de la Escalera G, Clapp C, Lavalle C: Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44:1331-1335.
20. Duenas Z, Torner L, Corbacho AM, Ochoa A, Gutierrez-Ospina G, Lopez-Barrera F, Barrios FA, Berger P, Martinez de la Escalera G, Clapp C: Inhibition of rat corneal angio-genesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest Oph-thalmol Vis Sci 1999; 40:2498-2505.
21. Cajero-Juarez M, Avila B, Ochoa A, Garrido-Guerrero E, Varela-Echavarria A, Martinez de la Escalera G, Clapp C: Immortalization of bovine umbilical vein endothelial cells: a model for the study of vascular endothelium. Eur J Cell Biol 2002; 81:1-8.
22. Neria F, Caramelo C, Peinado H, Gonzalez-Pacheco FR, Deudero JJ, de Solis AJ, Fernandez-Sanchez R, Penate S, Cano A, Castilla MA: Mechanisms of endothelial cell protection by blockade of the JAK2 pathway. Am J Physiol Cell Physiol 2007; 292: C1123-C1131.
23. Carley WW, Niedbala MJ, Gerritsen ME: Isolation, cultivation, and partial characterization of microvascular endothelium derived from human lung. Am J Respir Cell Mol Biol 1992; 7:620-630.
24. Tamanini C, De Ambrogi M: Angiogenesis in developing follicle and corpus luteum. Re-prod Domest Anim 2004; 39:206-216.
25. Gruemmer R, Klein-Hitpass L, Neulen J: Regulation of gene expression in endothelial cells: the role of human follicular fluid. J Mol Endocrinol 2005; 34:37-46.
26. Risau W: Mechanisms of angiogenesis. Nature 1997; 386:671-674.
27. Przala J, Grazul A, Wiesak T, Muszynska A, Dusza L: Steroid hormones and prolactin in porcine follicular fluid in estrous cycle and early pregnancy. Exp Clin Endocrinol 1985; 86:291-296.
28. Henderson KM, McNeilly AS, Swanston IA: Gonadotrophin and steroid concentrations in bovine follicular fluid and their relationship to follicle size. J Reprod Fertil 1982; 65:467-473.
29. Phelps JY, Bugg EM, Shamblott MJ, Vlahos NP, Whelan J, Zacur HA: Prolactin gene expression in human ovarian follicular cells. Fertil Steril 2003; 79:182-185.
30. Dunaif AE, Zimmerman EA, Friesen HG, Frantz AG: Intracellular localization of pro-lactin receptor and prolactin in the rat ovary by immunocytochemistry. Endocrinology 1982;110:1465-1471.
31. Wise T, Maurer RR: Follicular development, oocyte viability and recovery in relation to follicular steroids, prolactin and glycosami-noglycans throughout the estrous period in superovulated heifers with a normal LH surge, no detectable LH surge, and progestin inhibition of LH surge. Domest Anim Endo-crinol 1994; 11:35-58.
32. Bohnet HG, Baukloh V: Prolactin concentrations in follicular fluid following ovarian hyperstimulation for in vitro fertilization. Horm Res 1985; 22:189-195.
33. Lindner C, Lichtenberg V, Westhof G, Braendle W, Bettendorf G: Endocrine parameters of human follicular fluid and fertilization capacity of oocytes. Horm Metab Res 1988; 20:243-246.
34. Fraser HM, Lunn SF: Angiogenesis and its control in the female reproductive system. Br Med Bull 2000; 56:787-797.
35. von Otte S, Paletta JR, Becker S, Konig S, Fobker M, Greb RR, Kiesel L, Assmann G, Diedrich K, Nofer JR: Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. J Biol Chem 2006; 281:5398-5405.
36. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285:245-248.
37. Aranda J, Rivera JC, Jeziorski MC, Riesgo-Escovar J, Nava G, Lopez-Barrera F, Quiroz-Mercado H, Berger P, Martinez de la Escalera G, Clapp C: Prolactins are natural inhibitors of angiogenesis in the retina. Invest Oph-thalmol Vis Sci 2005; 46:2947-2953.
38. Tseng L, Zhu HH: Progestin, estrogen, and insulin-like growth factor-I stimulate the prolactin receptor mRNA in human endo-metrial stromal cells. J Soc Gynecol Investig 1998; 5:149-155.
39. Buscher U, Chen FC, Kentenich H, Schmia-dy H: Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction? Hum Reprod 1999; 14:162-166.
40. Corbacho AM, Macotela Y, Nava G, Eiserich JP, Cross CE, Martinez de la Escalera G, Clapp C: Cytokine induction of prolactin receptors mediates prolactin inhibition of nitric oxide synthesis in pulmonary fibro-blasts. FEBS Let t 2003; 544:171-175.
41. Matsumiya T, Imaizumi T, Itaya H, Shibata T, Yoshida H, Sakaki H, Kimura H, Satoh K: Production of growth related oncogene protein-alpha in human umbilical vein en-dothelial cells stimulated with soluble inter-leukin-6 receptor-alpha: role of signal transducers, janus kinase 2 and mitogen-activated kinase kinase. Life Sci 2002; 70:317 9-319 0.
42. Kochendoerfer SK, Krishnan N, Buckley DJ, Buckley AR: Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells. J Endocrinol 2003; 178:265-273.
43. Stocco C, Telleria C, Gibori G: The molecular control of corpus luteum formation, function, and regression. Endocr Rev 2007; 28:117-149.
44. Halperin J, Devi SY, Elizur S, Stocco C, She-hu A, Rebourcet D, Unterman TG, Leslie ND, Le J, Binart N, Gibori G: Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect. Mol Endocrinol 2008; 22:513-522.